Control of Stress-Induced Persistent Anxiety by an Extra-Amygdala Septohypothalamic Circuit  by Anthony, Todd E. et al.
Control of Stress-Induced Persistent
Anxiety by an Extra-Amygdala
Septohypothalamic Circuit
Todd E. Anthony,1 Nick Dee,2 Amy Bernard,2 Walter Lerchner,1,5 Nathaniel Heintz,3,4 and David J. Anderson1,4,*
1Division of Biology and Biological Engineering, California Institute of Technology, 1200 East California Boulevard, M/C 156-29, Pasadena,
CA 91125, USA
2Allen Institute for Brain Science, 551 North 34th Street, Suite 200, Seattle, WA 98103, USA
3Laboratory of Molecular Biology, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA
4Howard Hughes Medical Institute
5Present address: National Institutes of Health, Bethesda, MD 20892, USA
*Correspondence: wuwei@caltech.edu
http://dx.doi.org/10.1016/j.cell.2013.12.040SUMMARY
The extended amygdala has dominated research on
the neural circuitry of fear and anxiety, but the septo-
hippocampal axis also plays an important role. The
lateral septum (LS) is thought to suppress fear and
anxiety through its outputs to the hypothalamus.
However, this structure has not yet been dissected
using modern tools. The type 2 CRF receptor
(Crfr2) marks a subset of LS neurons whose func-
tional connectivity we have investigated using opto-
genetics. Crfr2+ cells include GABAergic projection
neurons that connect with the anterior hypothala-
mus. Surprisingly, we find that these LS outputs
enhance stress-induced behavioral measures of
anxiety. Furthermore, transient activation of Crfr2+
neurons promotes, while inhibition suppresses,
persistent anxious behaviors. LS Crfr2+ outputs
also positively regulate circulating corticosteroid
levels. These data identify a subset of LS projection
neurons that promote, rather than suppress, stress-
induced behavioral and endocrinological dimensions
of persistent anxiety states and provide a cellular
point of entry to LS circuitry.
INTRODUCTION
Stress is an etiologic factor in psychiatric disorders, especially
those involving anxiety (Gross and Hen, 2004; Feder et al.,
2009; Lupien et al., 2009). Consequently, considerable effort
has been made to map the neural circuits through which stress
promotes anxiety, most recently using optogenetic tools (Nieh
et al., 2013; Tye and Deisseroth, 2012). The majority of such
studies have focused on the extended amygdala (EA) (Davis
et al., 2010; Tye et al., 2011; Mahan and Ressler, 2012; Jennings
et al., 2013; Kim et al., 2013). The septohippocampal axis (SHA)
has also been implicated (Gray and McNaughton, 2000) but has522 Cell 156, 522–536, January 30, 2014 ª2014 Elsevier Inc.received less attention in the modern era. Several studies have
indicated a role for the ventral hippocampus in anxiety (Henke,
1990; Kjelstrup et al., 2002; Felix-Ortiz et al., 2013; Kheirbek
et al., 2013). However, the lateral septum (LS), a major compo-
nent of the SHA (Figure 1B), has been relatively neglected in
comparison to the intense focus on the EA.
The LS receives topographically organized inputs from the
hippocampus (Risold and Swanson, 1996) and is in turn recipro-
cally connected with the hypothalamus (Risold and Swanson,
1997b) (Figure 1A). It is also cellularly heterogeneous (Risold
and Swanson, 1997a). A variety of stressors induce immediate
early gene (IEG) expression in subsets of LS neurons (reviewed
in Sheehan et al., 2004). Furthermore, traumatic stress triggers
a persistent enhancement of LS IEG induction in response to
innately aversive stimuli (Mongeau et al., 2003). Importantly,
whether such stress-induced activation of the LS serves to pro-
mote, or rather to inhibit, persistent anxiety states is not clear.
Classical lesions of the septum, including both its medial and
lateral subdivisions, resulted in the dramatic ‘‘septal rage’’
phenotype, characterized by exaggerated defensive responses
to nonthreatening stimuli (Spiegel et al., 1940; Brady and Nauta,
1953). Reversible inactivation of the LS yielded similar pheno-
types (Albert and Richmond, 1976; Albert and Wong, 1978).
These and other data have led to a prevailing view that LS output
is anxiolytic, i.e., dampens fear or anxiety (reviewed in Sparks
and LeDoux, 2000; Sheehan et al., 2004).
Other studies, however, have implied an anxiogenic role for
the LS (Drugan et al., 1986; Treit and Pesold, 1990). For example,
LS injections of agonists of the type 2 corticotropin-releasing
factor receptor (CRFR2) have resulted in increased anxiety
(Radulovic et al., 1999; Bakshi et al., 2002; Henry et al., 2006).
However, it is not clear whether such agonists excite or inhibit
the neurons that express these receptors (Liu et al., 2004; Liu
et al., 2005). Indeed, Crfr2 mutations increase anxiety, implying
an anxiolytic function for the receptor (Bale and Vale, 2004).
These ambiguities, together with the unknown anatomy and con-
nectivity of Crfr2+ neurons, preclude any inferences of functional
LS circuitry to be made from such pharmacologic and genetic
data (Figures 1C and 1D).
Figure 1. Circuit Models for LS CRFR2+
Neuronal Regulation of Anxiety
(A) Sagittal plane of LS anatomy showing simplified
feedforward connections.
(B) Coronal section at plane indicated by dashed
line in (A). Modified from Allen Brain Atlas (www.
brain-map.org).
(C and D) Circuit models consistent with known
anxiogenic effect of CRFR2 agonists in the LS.
Depending on whether agonists excite (C) or inhibit
(D) CRFR2+ (‘‘R2’’) neurons, increased R2 neuronal
activity would be anxiogenic (C) or anxiolytic (D).
GABAergic R2 neurons (Figure 2F) may be local
interneurons (‘‘IN’’; C1, D3) or projection neurons
(‘‘PN’’; C2, D4). LS output may be anxiolytic (C1, D4)
or anxiogenic (C2, D3).As an initial step toward dissecting the circuitry through which
the LS regulates anxiety, we have gained genetic access to
Crfr2-expressing neurons and have used optogenetics, electro-
physiology, and anatomical mapping to understand how the
electrical activity of these neurons influences anxiety and the
connectivity through which this influence is exerted. We find,
contrary to the prevailing view, that Crfr2 marks LS output neu-
rons whose activity promotes, rather than inhibits, anxiety, in a
persistent manner. Thus, LS output does not serve exclusively
to suppress fear or anxiety in response to stressors (Sheehan
et al., 2004).
RESULTS
Crfr2 Expression Identifies a Subset of GABAergic LS
Neurons
In situ hybridization (ISH) revealed that Crfr2mRNA is expressed
by a subset of LS cells (Figures 2A–2E). Double-fluorescenceCell 156, 522–53ISH (dFISH) revealed that most Crfr2+
cells express the GABA biosynthetic gene
Gad2 (1,765/2,076 = 85.0%; Figure 2F),
whereas no overlap was detected with
either glutamatergic or cholinergicmarkers
(Figure S1 available online), indicating that
Crfr2 is expressed primarily by GABAergic
neurons. Comparison of Crfr2 mRNA to
that of Esr1 or Penk, two genes heteroge-
neously expressed in the LS (Risold and
Swanson, 1997a), indicated little or no
overlap at the single-cell level: Crfr2
versus Esr1, Crfr2+/DAPI+ = 8.3%, Esr1+/
DAPI+ = 1.7%; 8.3% 3 1.7% 3 11,086
cells counted = 15 Crfr2+Esr1+ cells ex-
pected if expression were random; no
Crfr2+Esr1+ cells were observed; Crfr2
versus Penk, Crfr2+/DAPI+ = 9.3%,
Penk+/DAPI+ = 3.3%; 9.3% 3 3.3% 3
8,274 cells counted = 25Crfr2+/Penk+ cells
expected if expression were random; one
Crfr2+Penk+ cell was observed (Figures
2G–2J). These data indicate that Crfr2+neurons are distinct from other molecularly defined populations
of LS cells.
To enable genetic manipulation of Crfr2+ neurons, we gener-
ated bacterial artificial chromosome (BAC) transgenic mice ex-
pressing an eGFPCre fusion protein (Gagneten et al., 1997) under
the control of the brain-selective alpha-splice variant of the Crfr2
gene (Figure 2K). Comparison by dFISH of eGFPCre expression
to that of endogenous Crfr2 mRNA indicated that 86.6% of
Cre+ cells contained Crfr2 mRNA; conversely, 34.4% of Crfr2
mRNA+ cells were Cre+ (Figures 2L and 2M). This indicates that
the BAC transgene is highly specific for Crfr2+ neurons but may
be expressed in a subset of such cells. Immunostaining revealed
thatmany eGFPCre+ cells are surrounded by pericellular baskets
containing UCN3, a CRFR2 peptide ligand (Figures 2N and 2O),
suggesting that these cells respond to this ligand in vivo.
To examine Cre-mediated recombination in Crfr2a-eGFPCre
mice, the LS was injected with a Cre-dependent (FLEx) adeno-
associated virus (AAV) encoding membrane-targeted tdTomato6, January 30, 2014 ª2014 Elsevier Inc. 523
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reporter (channelrhodopsin-2 [ChR2]-tdTomato[tdT] fusion)
(Atasoy et al., 2008) (Figure 2P). Almost 80% (77.9%) of tdT+
cells contained detectable eGFPCre+ nuclei (Figures 2Q and
2R). The presence of tdT in some eGFPCre cells may reflect
low and/or transient expression of Cre, coupled with the high
sensitivity and perdurance of fluorescent marker expression,
as observed in other Cre driver lines (Madisen et al., 2010).
In support of this idea, dFISH showed that 91.6% of tdT
mRNA+ cells wereCrfr2mRNA+ (Figures 2S and 2T). Importantly,
recombination did not occur in ESR1+ or Penk+ LS neurons (Fig-
ure S2). Thus, the Crfr2a-eGFPCre BAC transgene restricts
recombination of injected Cre-dependent viruses to LS Crfr2+
neurons.
Optogenetic Activation ofCrfr2a+Neurons Is Anxiogenic
Thevalenceof LSCrfr2a+neuronal activitywith respect to anxiety
is unclear. Although infusions ofCRFR2 receptor agonists into LS
have consistently yielded anxiogenic effects (Radulovic et al.,
1999; Bakshi et al., 2002; Henry et al., 2006; Bakshi et al.,
2007), slice recordings showed that receptor activation can
both inhibit (Liu et al., 2004) and potentiate (Liu et al., 2005)
neuronal activity. Consequently, it is unknown whether CRFR2
receptor activation increases anxiety through a decrease or an
increase in Crfr2a+ neuronal activity (Figures 1C and 1D). There-
fore, we tested whether direct activation of Crfr2a-expressing
neurons increases or decreases anxiety.
To do this, we targeted a ChR2 yellow fluorescent protein
(YFP) fusion to Crfr2a+ neurons by injecting a Cre-dependent
AAV (Figure 3A) into the LS of Crfr2a-eGFPCre mice. ChR2-
YFP was spatially correlated with Cre expression and restricted
to the LS, with no ChR2-YFP+ cell bodies detected outside of
this region (Figures 3B–3E and data not shown). Slice recordings
revealed that ChR2-YFP+ neurons could be efficiently and repet-
itively photostimulated at rates up to 15 Hz (Figures 3F–3H and
S3A–S3C). Although LS Crfr2a+ neuron in vivo firing rates are
unknown, single-unit recordings in the LS have observed spike
frequencies as high as 26 Hz (Thomas et al., 2005). Furthermore,
LS recordings during elevated plus maze (EPM) tests identified
units whose activity increased from 7.5 Hz in the closed
arms to 12.5 Hz in the open arms (Thomas et al., 2013). WeFigure 2. Characterization and Transgenic Targeting of LS Crfr2a+ Ne
(A–E) Crfr2 mRNA ISH; coronal diagrams in (A) depict region analyzed.
(F) dFISH for Crfr2 (green) and Gad2 (red).
(G and H) dFISH for Crfr2 (green) versus Esr1 (red): Crfr2+/DAPI+ = 8.3%, Esr1+/
(I and J) dFISH for Crfr2 (green) versus Penk (red): Crfr2+/DAPI+ = 9.3%, Penk+/D
cells
(K) Crfr2a-eGFPCre BAC transgene design.
(L and M) dFISH, Cre mRNA (green) versus Crfr2 mRNA (red): Crfr2+/DAPI+ =
n = 17,537 DAPI+ cells
(N andO) eGFPCre+ nuclei (green) versus UCN3 pericellular baskets (pcbs; red); co
with synaptophysin (data not shown). eGFPCre+/DAPI+ = 12.8%, UCN3pcb+/DA
total n = 2,665 Nissl+ cells
(P) Injection site (left) and Cre-dependent AAV (right).
(Q and R) Transgenic eGFPCre+ nuclei (green) versus recombined, viral tdT (re
DAPI+ = 6.3%, tdT+/eGFPCre+ = 42.1%, eGFPCre+/tdT+ = 77.9%; total n = 3,58
(S and T) dFISH forCrfr2mRNA (green) versus tdT mRNA (red); counts from areas
51.9%, Crfr2+/tdT+ = 91.6%; total n = 5,829 DAPI+ cells
In this and subsequent figures, dashed lines at left indicate lateral ventricle (LV)
See also Figures S1 and S2.therefore chose a photostimulation rate of 15 Hz, which is in
the range of natural firing rates of LS neurons in anxiogenic
environments.
Three behavioral tests of anxiety were used: light-dark box
(LDB), open field (OF), and novel object (NO) (Figures 3I and
3J); these tests were chosen because pharmacological experi-
ments showed them to be sensitive to modulation of LS Crfr2+
neuronal function (Henry et al., 2006). Photostimulation during
testing significantly increased anxiety levels in the ChR2 group
in all three assays relative to light-stimulated control animals in-
jected with a Cre-dependent AAV encoding hrGFP (Figure 3K).
Anxiogenic effects were also detected in the EPM (Figure S3D).
These effects were not due to a change in locomotor activity (Fig-
ure S3E). In the absence of light, no significant differences were
detected (Figure S3F). Thus, direct optogenetic stimulation of
Crfr2a+ neurons during behavioral testing increases anxiety
(Figure 3N).
Transient Activation of Crfr2a+ Neurons Causes a
Persistent State of Anxiety
One feature of anxiety states is their persistence. Therefore, we
tested whether transient optogenetic stimulation of Crfr2a+ neu-
rons might cause persistent anxiogenic effects. Pharmacolog-
ical approaches, such as injection of CRFR2 agonists, cannot
address this issue because once a drug is infused, the duration
of its action is unknown.
Mice subjected to 30 min of photostimulation were subse-
quently transferred to a separate room and behaviorally assayed
in the absence of photostimulation (Figures 3J and 3L). ChR2-
expressing mice showed increased levels of anxiety relative to
enhanced yellow fluorescent protein (eYFP) controls throughout
the 35 min testing period (Figure 3L) without differences in loco-
motor behavior (Figure S3G). Retesting of thesemice 7 days later
in the absence of additional photostimulation yielded no signifi-
cant differences in anxiety behavior (Figure S3H), indicating
that the anxious state induced by Crfr2a+ neuronal stimulation
is reversible. Furthermore, photostimulation at 1 Hz did not pro-
duce significant increases in anxiety (Figure S3I), suggesting that
the persistent effect of activating Crfr2a+ neurons is frequency
dependent.urons
DAPI+ = 1.7%, Crfr2+/Esr1+ = 0, Esr1+/Crfr2+ = 0; total n = 11,086 DAPI+ cells
API+ = 3.3%, Crfr2+/Penk+ = 0.1%, Penk+/Crfr2+ = 0.4%; total n = 8,274 DAPI+
9.3%, Cre+/DAPI+ = 3.7%, Cre+/Crfr2+ = 34.4%, Crfr2+/Cre+ = 86.6%; total
unts from areaswith detectable transgene expression. UCN3+ pcbs colocalize
PI+ = 11.8%, UCN3pcb+/eGFPCre+ = 65.2%, eGFPCre+/UCN3pcb+ = 71.0%;
d); counts from areas containing tdT+ cells. eGFPCre+/DAPI+ = 11.7%, tdT+/
6 DAPI+ cells
containing tdT+ cells.Crfr2+/DAPI+ = 12.5%, tdT+/DAPI+ = 7.1%, tdT+/Crfr2+ =
and boxed regions are shown at higher magnification in insets.
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The severity of a stressful encounter is thought to influence the
degree of its anxiogenic consequences (Adamec et al., 2006).
We therefore asked whether photostimulation of LSCrfr2a+ neu-
rons can exacerbate the anxiogenic effects of immobilization
stress (IMS). Mice were subjected to IMS for 30 min, throughout
which time they received photostimulation. During subsequent
testing done in a separate room in the absence of photostimula-
tion, ChR2 mice showed higher levels of anxiety behavior than
controls, indicating that stimulation of LS Crfr2a+ neurons and
IMS can combine to exacerbate anxiety (Figure 3M).
Crfr2a+ Neuronal Activity Is Necessary for the Induction
and Expression of a Stress-Induced, Sensitized State
The foregoing experiments indicated that stimulation of Crfr2a+
neurons is sufficient to increase anxiety in a persistent manner
but did not address whether the activity of these neurons is nor-
mally required for stress-induced anxiety. In principle, Crfr2a+
neuronal activity could be necessary for the induction or mainte-
nance (or both) of a persistent anxious state. To distinguish these
possibilities, we injected Crfr2a-eGFPCre mice with a Cre-
dependent AAV (Figure 4A) encoding YFP fused to the enhanced
halorhodopsin from Natronomonas pharaonis (eNpHR2.0), a
light-driven chloride pump that hyperpolarizes neurons in
response to yellow light (Gradinaru et al., 2008). A crescent-
shaped pattern of eNpHR-YFP protein was observed that was
restricted to LS and correlated closely with Cre+ cells (Figures
4B–4E; data not shown). Slice recordings confirmed that yellow
light produced outward currents that hyperpolarized eNpHR-
YFP+ neurons without detectable rebound firing even after pro-
longed, repeated photoinhibition (Figures S4A–S4D) and that
were sufficient to suppress current injection-induced firing (Fig-
ures 4F–4H).
To induce an anxious state, mice were subjected to 20 min of
IMS, after which they were transferred to the testing room and
behaviorally assayed (Figures 4I and 4J). To ascertain the
temporal roles of Crfr2a+ neurons, the LS was illuminated withFigure 3. Optogenetic Stimulation of LS Crfr2a+ Neurons Induces a Pe
(A) Cre-dependent ChR2-YFP AAV.
(B–D) Injection of (A) into Crhr2a-eGFPCre LS yielded ChR2-YFP (green) in Cre+
(E) Recombination specificity and sensitivity; counts done in areas containing ChR
ChR2+ = 79.7% ± 2.9%, ChR2+/Cre+ = 29.0% ± 2.1% (mean ± SEM). Total n =
(F) Top: ChR2 activity in Crfr2a+ cells assessed in acute slices. Bottom: pat
microscopy.
(G and H) Robust photocurrents were observed (G) that were sufficient to drive r
(I and J) Surgical manipulations and behavioral testing.
(K) Photostimulation ofCrfr2a+ neurons during behavioral testing increased anxiet
2.5 ± 0.6; p < 0.05), time in light side (58.6 ± 11.4 versus 21.0 ± 7.6; p < 0.01); OF,
versus 8.5 ± 1.2; p < 0.001); NO, entries in center (21.0 ± 2.6 versus 13.6 ± 2.0; p <
two-tailed unpaired t tests. Values indicate mean ± SEM. Bar height indicates m
(L) Photostimulation of Crfr2a+ neurons increased anxiety during subsequent tes
versus 7.6 ± 1.4; p < 0.01), time in light side (180.2 ± 24.8 versus 98.0 ± 20.1; p <
in center (16.3 ± 2.4 versus 9.2 ± 2.3; p < 0.01); NO (0–50), entries in center (21.7
p < 0.01). Bar height indicates mean, and error bars indicate SEM.
(M) Stimulating Crfr2a+ neurons exacerbates the anxiogenic effects of IMS (m
Procedures). hrGFP (n = 7) versus ChR2 (n = 8), data presented as Mann-Whitney
(U = 10.5, p < 0.05); OF, entries in center (U = 15.5; p > 0.15), time in center (U = 2
p < 0.05). In the column bar graph, the bar height indicates mean and error bars in
percentiles, the line in the middle indicates median, and whiskers denote minimu
(N) Model of LS Crfr2a+ neuronal valence based on optogenetic stimulation.
See also Figure S3.593 nm light either during IMS or subsequent testing. Photoinhi-
bition of Crfr2a+ neurons produced significant anxiolytic effects
in eNpHR-injected mice relative to hrGFP controls, regardless of
whether inhibition was done during IMS or testing (Figures 4L
and 4K). No differences in locomotor behavior were observed
(Figures S4E and S4F). In the absence of 593 nm light, no differ-
ences were observed between groups (Figure S4H). Compari-
sons of light-on versus light-off periods indicated that the
anxiolytic effects were predominant during illumination and
therefore unlikely to be due to rebound firing following photoinhi-
bition offset (Figure S4G).
One caveat was the possibility that the testing environment
itself is highly stressful. If so, then the anxiolytic effects of inhibi-
tion during testing (Figure 4L) might reflect a role for Crfr2a+ neu-
rons in responding to the stress of the testing conditions rather
than in the expression of a previously established sensitized
state. However, no significant reduction in anxiety was observed
when photoinhibition ofCrfr2a+ neurons was done during testing
inmice that had not undergone IMS (Figure 4M). These data sug-
gest that ongoing activity of Crfr2a+ neurons is required for both
the induction and persistence of a stress-induced anxious state
(Figure 4N). Taken together, our gain- and loss-of-function data
indicate that the activity of Crfr2a+ neurons exerts a net anxio-
genic influence (Figure 1C).
LS Crfr2a+ GABAergic Projections to the Anterior
Hypothalamus Mediate Persistent Stress-Induced
Anxiety
It is not known whether LS Crfr2a+ neurons are interneurons or
projection neurons, nor have their synaptic targets been identi-
fied. Therefore, their anxiogenic influence could reflect either a
local, intraseptal (interneuron) or extraseptal (projection neuron)
function (Figure 1C, 1 versus 2). To determine whether LS
Crfr2a+ neurons have extraseptal projections, ChR2-YFP was
used as an anterograde label (Figure 5A). Strong somatoden-
dritic labeling of neurons was observed, as was a robustrsistent Anxious State
cells (red).
2-YFP+ cells: ChR2+/DAPI+ = 4.6% ± 1.1%, Cre+/DAPI+ = 12.4% ± 1.7%, Cre+/
9,673 DAPI+ cells from two mice.
ched YFP+ neuron under infrared differential interference contrast (IR-DIC)
epetitive, tetrodotoxin(TTX)-sensitive spiking in ChR2-YFP+ neurons (H).
y. hrGFP(n = 39) versus ChR2(n = 38): LDB, entries in light side (4.6 ± 0.8 versus
entries in center (11.0 ± 1.2 versus 6.4 ± 0.9; p < 0.01), time in center (17.9 ± 2.1
0.05), time in center (44.7 ± 6.8 versus 24.9 ± 5.1; p < 0.05). p values represent
ean, and error bars indicate SEM.
ting. eYFP (n = 13) versus ChR2 (n = 12): LDB, entries in light side (15.2 ± 1.7
0.05); OF (0–50 ), entries in center (12.2 ± 1.8 versus 6.3 ± 1.0; p < 0.01), time
± 2.8 versus 13.0 ± 2.0; p < 0.05), time in center (55.4 ± 8.7 versus 25.3 ± 5.0,
ice were habituated to minimize ceiling effect confound; see Experimental
U value, p value: LDB, entries in light side (U = 7.5, p < 0.05), time in light side
2.5; p > 0.55); NO, entries in center (U = 7.0; p < 0.05), time in center (U = 10.0;
dicate SEM. In the box and whisker plot, the box extends from the 25th to 75th
m and maximum data values.
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projection of YFP+ axons coursing ventrally out of the LS (Figures
5B–5D). The extraseptal region containing the densest cluster of
axons was the anterior hypothalamic area (AHA) of the medial
hypothalamus (Figures 5E and 5F), with lighter innervation seen
in more rostral and caudal hypothalamic areas, medial amyg-
dala, periaqueductal gray, and ventral hippocampus (Figures
S5A–S5L). Notably, the paraventricular nucleus (PVN), which is
part of the hypothalamic-pituitary-adrenocortical (HPA) axis
(reviewed in Ulrich-Lai and Herman, 2009), appeared to exclude
Crfr2a+ axons (Figure 5G).
To further characterize these putative long-range targets of
Crfr2a+ neurons, we iontophoresed cholera toxin subunit B
(CTB) into theAHAofCrfr2a-eGFPCremice (Figure5H). Atmiddle
coronal levels of LS (bregma+0.6), backlabeled neurons formed
a crescent pattern that overlapped with Crfr2a+eGFPCre+ cell
bodies (Figures 5I and 5J). Moreover, the overlap of eGFPCre
and CTB at the single-cell level was significantly higher than
that expected by chance (Figure 5K). In contrast, significantly
fewerCrfr2a+eGFPCre+ neuronswere labeled than that expected
by chance when CTB was iontophoresed into the lateral
hypothalamus (LH, a known target of LS innervation; Risold and
Swanson, 1997b; Sartor and Aston-Jones, 2012), despite
similar numbers of back-labeled LS cells (Figures 5L–5O). These
data suggest that Crfr2a-expressing cells at middle levels
(bregma+0.6) of LS preferentially project to AHA versus LH.
To determine the postsynaptic effects of stimulating Crfr2a+
axons, we employed ChR2-assisted circuit mapping (CRACM)
(Petreanu et al., 2007) to assay postsynaptic responses in AHA
neurons near ChR2-YFP+ axons (Figure 5P). In six of nine cells
tested, 473 nm light evoked picrotoxin-sensitive inhibitory post-
synaptic currents (IPSCs) (average amplitude = 71.3 ± 5.3pA)
(Figure 5Q, top). Responses occurred with a latency of 5.0 ±
0.4 ms, consistent with monosynaptic connectivity (Debanne
et al., 2008). Moreover, photostimulation was sufficient to inhibit
spiking in postsynaptic cells (Figure 5Q, bottom). Similar results
were obtained from local intraseptal targets of Crfr2a+-ChR2-
expressing neurons in LS slice recordings (Figures S5M and
S5N). Thus, LSCrfr2a+ projection neurons form inhibitory synap-Figure 4. LS Crfr2a+ Neurons Are Necessary for the Induction and Exp
(A) Cre-dependent eNpHR(2.0)-YFP AAV.
(B–D) Injection of (A) into Crhr2a-eGFPCre LS yielded eNpHR-YFP (green) in Cre
(E) Recombination specificity and sensitivity; counts from areas containing eNp
Cre+/eNpHR+ = 71.2% ± 1.6%, eNpHR+/Cre+ = 29.8% ± 3.0% (mean ± SEM). T
(F–H) Recordings from eNpHR-YFP+Crfr2a+ neurons. (G) Cell in response to the sa
(H) 593 nm light significantly suppressed firing of eNpHR-YFP+ neurons (F1,108 =
(I and J) Surgical manipulations and behavioral testing.
(K) Photoinhibition of Crfr2a+ neurons only during IMS reduced anxiety in subse
WhitneyU value, p value: LDB, entries in light side (U = 64.0; p < 0.05), time in light
(U = 64.5; p < 0.05); NO, entries in center (U = 73.5; p < 0.05), time in center (U = 34
middle indicates median, and whiskers denote minimum and maximum data val
(L) IMS mice that received photoinhibition of Crfr2a+ neurons only during behavio
eNpHR (n = 11): LDB, entries in light side (U = 21.5; p < 0.01), time in light side (U =
p < 0.05); NO, entries in center (U = 22.0; p < 0.05), time in center (U = 21.0; p <
indicates median, and whiskers denote minimum and maximum data values.
(M) InhibitingCrfr2a+ neurons in the absence of IMS does not alter anxiety. hrGFP (
2.3; p > 0.9), time in light side (218.7 ± 44.6 versus 206.4 ± 45.2; p > 0.8); OF, ent
versus 26.7 ± 4.4; p > 0.15); NO, entries in center (43.0 ± 6.3 versus 39.0 ± 3.9;
(N) Model for LS Crfr2a+ neuronal valence based on optogenetic inhibition.
See also Figure S4.ses with target neurons in the AHA. Neurons in this population
also make local inhibitory synapses within the LS. Whether these
local and long-range synapses aremade by the same or different
Crfr2a+ neurons is not clear.
The existence of projections to the AHA does not in itself
establish a role for these connections in the anxiogenic influence
of Crfr2a+ neuronal activity, becuase it remained possible that
such effects are mediated principally via local intraseptal synap-
ses. To test the requirement of projections to the AHA for the
expression of stress-induced anxiety, we employed the archaer-
hodopsin ArchT, a light-driven proton pump that hyperpolarizes
neurons in response to green light and efficiently traffics to
axonal termini (Han et al., 2011). Injection of a Cre-dependent
AAV (Figure 6A) into Crfr2a-eGFPCre LS yielded ArchT expres-
sion in a pattern that correlated with Cre and enabled photoinhi-
bition of cell bodies and axons (Figures S6B–S6M).
Photoinhibition of LS Crfr2a+ terminal fields in the AHA during
behavioral testing following IMS produced significant anxiolytic
effects without altering locomotor behavior, and no significant
differences were observed in the absence of 532 nm light (Fig-
ures 6B–6E, S6N, and S6O). Conversely, optogenetic stimulation
using ChR2-YFP of LS Crfr2a+ axon terminals in the AHA during
testing was anxiogenic in the LDB and OF assays, albeit more
weakly than was observed using LS cell body stimulation (Fig-
ures 6F–6J); locomotor behavior was unaffected (Figure S6P).
Antidromic stimulation of LS cell bodies may contribute to the
behavioral effects of optogenetic terminal activation but cannot
be exclusively responsible given that photoinhibition of terminals
in this region using ArchT was anxiolytic (Figure 6E). Together,
these data suggest that LS Crfr2a+ neurons exert anxiogenic
effects, at least in part, via inhibitory projections to the AHA (Fig-
ures 1C and 2).
LS Crfr2a+ Neurons Make Disynaptic Connections with
PVN via AHA
Despite strong innervation by LS Crfr2a+ axons of the adjacent
AHA, the PVN appears devoid of such projections (Figure 5G).
Given the role of the PVN in the stress response, we askedression of a Stress-Induced, Anxiogenic State
+ cells (red).
HR-YFP+ cells: eNpHR+/DAPI+ = 4.7% ± 0.2%, Cre+/DAPI+ = 11.4% ± 0.4%,
otal n = 8,216 DAPI+ cells from two mice.
me current injections in the absence (top) or presence (bottom) of 593 nm light.
28.69; p < 0.001).
quent testing. hrGFP (n = 15) versus eNpHR (n = 17), data presented Mann-
side (U = 62.5; p < 0.05); OF, entries in center (U = 69.0; p < 0.05), time in center
.0; p < 0.001). The box extends from the 25th to 75th percentiles, the line in the
ues.
ral testing showed reduced anxiety relative to controls. hrGFP (n = 11) versus
20.0; p < 0.01); OF, entries in center (U = 25.5; p = 0.07), time in center (U = 23.0;
0.05). The box extends from the 25th to 75th percentiles, the line in the middle
n = 11) versus eNpHR (n = 11): LDB, entries in light side (11.5 ± 1.9 versus 11.7 ±
ries in center (23.1 ± 2.6 versus 20.4 ± 2.8; p > 0.45), time in center (34.4 ± 3.2
p > 0.6), time in center (97.0 ± 15.8 versus 97.5 ± 14.9; p > 0.95).
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Figure 5. LS Crfr2a+ Neurons Make GABAergic Synapses in the AHA
(A–G) Cre-dependent ChR2-YFP AAV injected into Crfr2a-eGFPCre LS labeled cell bodies (arrowhead in B, enlarged in C) and axons (arrow in B, enlarged in D).
Terminals were densest in AHA (E). All AHA labeling was axonal (F, enlarged from boxed area in E). YFP+ axons appeared to be excluded from the PVN (G).
ac, anterior commissure; f, fornix; PVN, paraventricular hypothalamic nucleus.
(legend continued on next page)
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whether the PVN might be a higher-order target of LS Crfr2a+
neurons. To test for evidence of polysynaptic connectivity,
we used the herpes simplex virus (HSV) strain HSV129DTK-TT
(Figure 7A), a Cre-dependent transneuronal tracer that moves
exclusively in the anterograde direction (Lo and Anderson,
2011).
At 1 day following delivery of the virus into the LS of Crfr2a-
eGFPCre mice, scattered tdT+ cells were observed near the
injection site (Figure 7B), but not in any other region. By
3 days postinjection, tdT labeling was extensive throughout
the LS on the side ipsilateral to injection (Figure 7C) and
many tdT+ cells were now detectable bilaterally in both the
AHA and PVN (Figure 7D), consistent with di- or polysynaptic
transfer to the latter structure. Many tracer-labeled AHA neu-
rons were GABAergic (Figures S7E–S7H). The anterogradely
labeled dorsolateral PVN cells were located in a region known
to contain parvicellular CRF+ neurons of the mouse PVN that
are responsible for initiating the stress responses (Biag et al.,
2012). No tdT fluorescence was detected when HSV129DTK-
TT was injected into the LS of nontransgenic animals (data
not shown).
To test whether LS Crfr2a+ neurons monosynaptically inhibit
AHA neurons that innervate the PVN, Crfr2a-eGFPCre mice
were coinjected in the LS with Cre-dependent ChR2-YFP and
in the PVN with retrobeads (RB; retrograde tracer) (Figures 7E
and 7F). Recordings of RB+ cells in the AHA identified four out
of nine cells that showed monosynaptic IPSCs in response to
a 2 ms pulse of 473 nm light (average amplitude = 74.6 ±
33.4pA; average latency = 5.5 ± 0.1 ms) and that were sufficient
to inhibit firing (Figure 7G). Taken together with the results of the
HSV129DTK-TT anterograde tracing, these data demonstrate
that LS Crfr2a+ neurons make disynaptic connections to the
PVN via their projections to the AHA. Similar experiments indi-
cated that LS Crfr2a+ neurons also form inhibitory synapses on
AHA neurons that project to the midbrain periaqueductal gray
(PAG; Figures S7I–S7L), a region known to regulate defensive
behaviors relevant to anxiety (Bandler and Shipley, 1994;
Almeida-Santos et al., 2013).
AHA-Projecting LS Crfr2a+ Neurons Positively Regulate
Corticosterone Levels
The PVN is innervated by GABAergic AHA neurons implicated in
glucocorticoid-induced negative feedback regulation of HPA
axis function (Paca´k and Palkovits, 2001; Herman et al., 2002).
Our data suggest that LS Crfr2a+ neurons inhibit GABAergic
targets in AHA that in turn project to PVN. If so, then LS Crfr2+
neurons should exert a net positive-acting influence on PVN(H–O) CTB retrograde tracing. eGFPCre (green) and CTB (red) in the LS of Crfr2a-
LH (M,N). (K) A significant fraction of Crfr2a+ neurons project to AHA (CTB+/DA
Crfr2a+ neurons comprise a large fraction of the neurons that project to AHA from
42.0% ± 3.1%; p < 0.001). (O) Few Crfr2a+ neurons innervate the LH (CTB+/DAPI+
projections to this region coming from Crfr2a– cells (GFPCre+/DAPI+ = 5.9% ±
bregma+0.6 in LS regions that contained CTB+ cells. Total n = 7,737 DAPI+ cells (A
bar height indicates mean and error bars indicate SEM.
(P and Q) CRACM in standard ACSF or plus 100 mM picrotoxin (PTX). (Q) Single
temporal resolution to illustrate response latency. Bottom: picrotoxin-sensitive inh
(15 Hz, 2 ms pulses).
See also Figure S5.function, via a presumptive di-synaptic disinhibitory connection.
To test this idea, wemeasured corticosterone (CORT) levels as a
surrogate index of PVN activation, because the PVN positively
regulates the HPA axis.
LS Crfr2a+ neurons were optogenetically stimulated for
30 min, followed immediately by blood collection (Figure 7H).
Control experiments indicated that experimental handling, in-
cluding anaesthetization, of animals elevates circulating CORT
(data not shown), and baseline CORT was elevated in eYFP
control mice, indicating that the HPA axis was activated under
the testing conditions. Nevertheless, optogenetic stimulation
yielded significantly higher levels of CORT in ChR2-injected
mice relative to eYFP controls (Figure 7I).
We next tested whether optogenetic inhibition of LSCrfr2+ ter-
minals in AHA would, conversely, reduce CORT (Figure 7J). To
maximize CORT levels, mice were subjected to IMS during pho-
toinhibition. Although CORT levels in IMS-treated controls were
similar to those in non-IMS-treated controls (Figure 7I versus 7K),
reflecting the constitutive activation of the HPA axis under these
conditions, optogenetic inhibition yielded a statistically signifi-
cant reduction in CORT (Figure 7K). Together, these gain- and
loss-of-function data indicate that LS Crfr2+ neurons positively
modulate CORT levels in the context of an activated HPA axis.
They are, therefore, consistent with the idea that these neurons
exert a net positive-acting influence on PVN function.
DISCUSSION
The LS has long been implicated in the control of stress re-
sponses and anxiety but has not previously been subjected to
functional dissection of its genetically defined constituent
neuronal subpopulations. Here, we have used an optogenetic
approach to trace and functionally manipulate LS Crfr2a+ neu-
rons. We report three major findings regarding their role in
anxiety. First, the valence of LS Crfr2a+ neuronal activation is
anxiogenic. Second, these effects are mediated at least in part
via extraseptal projections to the AHA rather than by an exclu-
sively intraseptal mechanism. Lastly, transient activation of LS
Crfr2a+ neurons can induce both behavioral and neuroendocrine
dimensions of a persistent anxiety state.
Crfr2 Marks LS Output Neurons with an Anxiogenic
Influence
The robust and dramatic septal rage phenotype that results from
certain electrolytic, physical, or chemical lesions of the septum
(Spiegel et al., 1940; Brady and Nauta, 1953; Albert and Rich-
mond, 1976) has led to a prevailing view that the output of theeGFPCre mice that received iontophoretic injection of CTB into the AHA (I,J) or
PI+ = 4.3% ± 0.7% versus CTB+/eGFPCre+ = 33.0% ± 1.0%; p < 0.001), and
middle levels of LS (GFPCre+/DAPI+ = 5.5% ± 1.1% versus eGFPCre+/CTB+ =
= 3.8% ± 0.01% versus CTB+/eGFPCre+ = 1.8% ± 0.1%; p < 0.01), with most
0.4% versus eGFPCre+/CTB+ = 2.8% ± 0.1%; p < 0.05). Counts done at
HA) and n = 5,767 DAPI+ cells (LH). Values indicate mean ± SEM. In (K) and (O),
2 ms pulses of 473 nm light evoked IPSCs blocked by PTX (top). Inset: higher
ibition of spontaneous firing observed by presynaptic terminal photostimulation
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Figure 6. LS Crfr2a+ Projections to AHA Are Necessary for Stress-Induced Anxiety
(A) Cre-dependent ArchT-GFP AAV.
(B–E) Axon terminal inhibition. (C,D) ArchT-GFP in LSCrfr2a+ (C) cell bodies and (D) and axons in AHA. (E) Photoinhibition ofCrfr2a+ axon terminals in AHA during
behavioral testing in IMS-stressedmice reduces anxiety. hrGFP (n = 10) versus ArchT (n = 12), data presentedMann-WhitneyU value, p value: LDB, entries in light
side (U = 25.0; p < 0.05), time in light side (U = 24.0; p < 0.05); OF (5–100), entries in center (U = 21.5; p < 0.05), time in center (U = 26.0; p < 0.05); NO (0–50), entries in
center (U = 29.5; p < 0.05), time in center (U = 19.0; p < 0.05). In (E), the box extends from the 25th to 75th percentiles, the line in the middle indicates median, and
whiskers denote minimum and maximum data values.
(F) Cre-dependent ChR2-YFP AAV.
(G–J) Axon terminal stimulation. (H and I) ChR2-YFP in LS Crfr2a+ (H) cell bodies and (I) axons. (J) Stimulation of Crfr2a+ axon terminals in AHA during testing
increased anxiety. eYFP (n = 17) versus ChR2 (n = 15): LDB, entries in light side (5.2 ± 1.6 versus 2.5 ± 0.4; p > 0.1), time in light side (79.9 ± 23.2 versus 20.3 ± 4.6;
p < 0.05); OF, entries in center (15.1 ± 2.3 versus 7.4 ± 1.3; p < 0.01), time in center (26.8 ± 4.2 versus 9.5 ± 1.8, p < 0.01); NO, entries in center (32.9 ± 5.0 versus
22.5 ± 2.9; p = 0.08), time in center (77.2 ± 15.2 versus 74.9 ± 18.3; p > 0.1); values indicate mean ± SEM. p values represent two-tailed unpaired t tests. In (J), bar
height indicates mean and error bars indicate SEM.
Dashed lines in (D) and (I) indicate guide tips.
See also Figure S6.
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Figure 7. LS Crfr2a+ Projections to AHA Are Polysynaptically Upstream of PVN and Positively Regulate Corticosterone Levels
(A and A0) HSV129DTK-TT.
(B–D) tdT (red) in HSV129DTK-TT-injected Crfr2a-eGFPCre mice counterstained with DAPI (blue) at 1 (B) or 3 (C and D) days postinjection (dpi) in LS (B and C) or
medial hypothalamus (D). Dashed lines in (D) demarcate PVN (upper right) and AHA (lower left).
(E–G) Combined CRACM and retrograde tracing. (F) A slice used for recording; Crfr2a+ChR2-YFP+ axons originating from LS (green), retrobeads (red), and two
neurobiotin-filled neurons (blue). The cell that yielded the traces in (G) is shown at higher magnification in the inset. (G) A 2 ms pulse of 473 nm light induced
monosynaptic IPSCs in four out of nine retrobead+ AHA neurons that were sufficient to inhibit firing (G0).
(H and I) Optogenetic stimulation of LS Crfr2a+ neurons increased CORT. eYFP (n = 9) versus ChR2 (n = 9): CORT, ng/ml (159.2 ± 9.3 versus 228.8 ± 30.9;
p < 0.05). In (I), bar height indicates mean and error bars indicate SEM.
(J and K) Optogenetic inhibition of LS Crfr2a+ projections to AHA decreased CORT. hrGFP (n = 15) versus ArchT-GFP (n = 17): CORT, ng/ml (162.1 ± 8.6 versus
134.5 ± 4.1; p < 0.01). In (K), bar height indicates mean and error bars indicate SEM.
Values indicate mean ± SEM.
(L) Proposed model for LS Crfr2a+ neuronal control of stress-induced anxiety.
See also Figure S7.
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LS serves to dampen fear and anxiety (Sheehan et al., 2004).
Anxiogenic cell populations in the LS were, therefore, inferred
to act by providing local inhibition on such anxiolytic output
(Henry et al., 2006). Here, we identify a subpopulation of LS
output neurons whose activation is anxiogenic rather than anxi-
olytic. This anxiogenic influence is exerted, at least in part, via
long-range inhibitory projections to the medial hypothalamus.
These data argue against the long-standing view that LS output
serves primarily to suppress fear or anxiety in response to
stressors (Sheehan et al., 2004).
Importantly, we note that our data derive from a transgenic
mouse line that drives detectable Cre expression in a subset of
Crfr2mRNA+ cells. This incomplete expressivity of the transgene
could reflect either stochastic variation or expression in a deter-
ministic subset of Crfr2+ neurons due to incomplete capture of
the entire transcriptional control region in the transgene. What-
ever the explanation, the fact that complementary gain- and
loss-of-function optogenetic phenotypes were observed argues
that the Cre+Crfr2+ subset plays an important role in the regula-
tion of anxiety. However, our experiments leave open the rela-
tionship of Cre, Crfr2+ cells to anxiety.
LS Crfr2a+ Neurons Act via Inhibitory Projections to the
Medial Hypothalamus
Our optogenetic studies demonstrate that the anxiogenic effects
of LS Crfr2a+ neuronal activity are exerted, at least in part, via
GABAergic projections to the medial hypothalamus (Figure 1,
model 2; Figures 6E and 6J). These inhibitory projections exert
a positive-acting influence on both the behavioral and endocri-
nological dimensions of a stress-induced anxious state. These
effects are mediated at least in part via the inhibition of
GABAergic targets within the AHA (Figures 7L and S7A–S7H).
These AHA target neurons innervate the PVN, a structure that
regulates CORT release. Our experiments implicate LS Crfr2a+
neurons in the regulation of circulating glucocorticoids. To our
knowledge, optogenetic manipulations of specific neuronal sub-
populations that lead to changes in corticosterone levels have
not previously been reported. However, whether this endocrino-
logical effect explains the persistent elevation of anxiety is
unclear. Indeed, our observation that AHA targets of LS Crfr2a+
neurons also project to the PAG raises the possibility that
the behavioral and endocrinological influences of LS Crfr2a+
neuronal activity may be mediated by parallel neural pathways,
as demonstrated in the extended amygdala (LeDoux et al.,
1988; Viviani et al., 2011; Kim et al., 2013).
Our data do not exclude the possibility that some LS Crfr2a+
neurons also act intraseptally to promote anxiety, for example
by inhibiting anxiolytic LS subpopulations. The existence of anxi-
olytic neurons is supported by the observation that excitotoxic
LS lesions can enhance stress-induced activation of the HPA
axis (Singewald et al., 2011). LS neurons in general are thought
to send recurrent GABAergic collaterals that terminate on
other neurons throughout the LS (Sheehan et al., 2004). These
data suggest that the level of stress-induced anxiety may be
controlled by a balance of activity between anxiogenic and anxi-
olytic LS populations. It has recently been shown that the BNST
contains distinct anxiogenic and anxiolytic GABAergic neuronal
subsets with unique patterns of long-range connections (Jen-534 Cell 156, 522–536, January 30, 2014 ª2014 Elsevier Inc.nings et al., 2013; Kim et al., 2013). Whether specific anxiolytic
output neurons exist in the LS, in addition to the anxiogenic out-
puts identified here, remains to be determined.
LS Crfr2a+ Neurons Can Generate Persistent States of
Anxiety
The time-resolved nature of optogenetic manipulations has
revealed that transient activation of LS Crfr2a+ neurons can
induce anxiety that persists for at least half an hour following
the offset of photostimulation. Other optogenetic manipulations
have revealed rapidly reversible effects on anxiety. For example,
photostimulation of excitatory basolateral amygdala projections
to central amygdala resulted in an acute anxiolytic effect that
rapidly dissipated upon cessation of stimulation (Tye et al.,
2011). Similarly, optogenetic stimulation of Drd1a+ neurons in
the oval nucleus of BNST acutely but reversibly elevated anxiety
(Kim et al., 2013). In contrast, photostimulation of glutamatergic
projections from ventral BNST to the ventral tegmental area
(VTA) (Jennings et al., 2013) was sufficient to induce a persistent
elevation in anxiety. These results suggest that distinct pathways
may be responsible for controlling acute versus persistent
anxiety. It is additionally interesting to note that the two path-
ways thus far found to display persistence (vBNST-VTA and
LS-AHA) are both anxiogenic. It remains to be seen whether
persistent anxiolytic pathways exist or if persistence is rather a
unique property of circuits that elevate anxiety.
The present studies have identified a cellular point of entry to
an important but understudied node in the brain circuitry that
regulates emotional responses to stress. Our results provide
further evidence of the importance of long-range GABAergic
projection neurons in the control of anxiety (Jennings et al.,
2013; Kim et al., 2013). Future studies should reveal the inputs
to LSCrfr2+ neurons, the interactions of these neurons with other
genetically and functionally distinct LS subpopulations, and the
functional relationship between the SHA and the extended
amygdala in the control of anxiety. Together, such studies
should provide a neural-circuit-level framework for understand-
ing how genetic and environmental factors shape an individual’s
response to stress and may identify new potential routes for
therapeutic intervention in anxiety disorders.
EXPERIMENTAL PROCEDURES
Generation of Crfr2a-eGFPCre BAC Transgenic Mice
A BAC (clone RP23-78P13) containing the mouseCrfr2 gene was subjected to
two rounds of RecA-mediated homologous recombination to (1) disrupt
expression of Inmt, a gene present on the BAC and known to be expressed
in the brain; and (2) insert an eGFPCre-SV40pA cassette at the start codon
in the third exon of the brain-selective alpha-splice variant of the Crfr2 gene.
The final recombineered BAC was linearized with NotI, purified using Sephar-
ose CL4b, confirmed by pulsed field gel electrophoresis, and then microin-
jected into the pronuclei of FVB/N embryos to generate transgenic mice.
Animal Maintenance
The Crfr2a-eGFPCre BAC transgene was maintained on an FVB/N (Taconic)
background. For behavior experiments, hemizygous transgenic FVB/N males
were bred to nontransgenic C57BL/6N (Harlan Sprague-Dawley) females and
FVBB6F1 male transgenics were used for testing. Animals were housed at
23C with ad libitum access to food and water in a 13 hr day/11 hr night cycle,
with the day starting at 21:00. Behavioral testing was done during the dark
cycle, starting no earlier than 11:00 and no later than 20:00. Following surgery,
mice were singly housed. All experiments were conducted in accordance with
National Institutes of Health guidelines and approved by the Caltech Institu-
tional Animal Care and Use Committee.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2013.12.040.
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